SCHEMBL29633739

SCHEMBL29633739

COc1ccc(CC(C(=O)O)N(C)C(=O)OCC2c3ccccc3-c3ccccc32)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 2/20 0.41
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.37
KLKB1 P03952 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
FABP7 O15540 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
CACNA1G O43497 1/20 0.35
CACNA1H O95180 1/20 0.35
CACNA1I Q9P0X4 1/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
MDM2 Q00987 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30054744 1.00 FABP5 (0.41) FABP5ITGB3ITGA2BPPARGPPARA
SCHEMBL25355198 1.00 FABP5 (0.41) FABP5ITGB3ITGA2BPPARGPPARA
SCHEMBL25182963 1.00 FABP5 (0.41) FABP5ITGB3ITGA2BPPARGPPARA
SCHEMBL25183125 1.00 FABP5 (0.41) FABP5ITGB3ITGA2BPPARGPPARA
SCHEMBL25357875 0.91 FABP5 (0.40) FABP5PPARGPPARATAS2R14KMT2A
SCHEMBL29633807 0.91 FABP5 (0.40) FABP5PPARGPPARATAS2R14KMT2A
SCHEMBL25357871 0.91 FABP5 (0.40) FABP5PPARGPPARATAS2R14KMT2A
SCHEMBL25657534 0.89 FABP5 (0.37) FABP5ITGB3ITGA2BTAS2R14KLKB1
SCHEMBL29633905 0.89 FABP5 (0.37) FABP5ITGB3ITGA2BTAS2R14KLKB1
SCHEMBL25179614 0.88 ITGB3 (0.40) FABP5ITGB3ITGA2BPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885ITGB3 4722/4885ITGA2B 4737/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885ITGB3 4722/4885ITGA2B 4737/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR FABP5 608/4885ITGB3 4722/4885ITGA2B 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.